By activating caspase 8, a SPARC N‐terminal peptide may improve the apoptotic cascade and resensitize chemotherapy‐resistant human colon, breast, and pancreatic cancer cells to treatment [17]. This evidence concerns the gene SPARC and familial pancreatic carcinoma.